Home  »  Finance   »  APGN’s Market Whiplash: -22.99% YTD Decline,...

APGN’s Market Whiplash: -22.99% YTD Decline, 15.43% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -22.99% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -71.30%. Over the past 30 days, the price of APGN has fallen by 15.43%. And in the last five days, it has surged by 38.58%.

The stock of Apexigen Inc. (APGN) is currently priced at $0.53. In the last session, the stock climbed significantly, topping out at $0.404 after opening at $0.404. The day’s lowest price was $0.36 before the stock closed at $0.40.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Apexigen Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $31.35 on 08/01/22, while the lowest price for the same period was registered at $0.33 on 05/15/23.

52-week price history of APGN Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Apexigen Inc.’s current trading price is -98.32% away from its 52-week high, while its distance from the 52-week low is 58.91%. The stock’s price range during this time has been between $0.33 and $31.35. The trading volume for the Healthcare sector company’s shares reached about 5.5 million for the day, which was higher than the average daily volume of 0.11 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Apexigen Inc. (APGN) has experienced a quarterly decline of -61.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.94M and boasts a workforce of 20 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9245, with a change in price of -0.1769. Similarly, Apexigen Inc. recorded 1,437,568 in trading volume during the last 100 days, posting a change of -23.68%.

APGN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for APGN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

APGN Stock Stochastic Average

Today’s raw stochastic average for Apexigen Inc. over the last 50 days is 51.01%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 66.62%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 33.69% and 23.84%, respectively.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts